Cite
HARVARD Citation
Saleh, M. et al. (n.d.). SO-008Ramucirumab plus merestinib in previously treated metastatic colorectal cancer: safety, pharmacokinetic, and preliminary efficacy findings from a Phase 1 study. Annals of oncology. p. . [Online].